Erbitux slightly boosts survival in cancer study
Sunday, June 1, 2008 - 03:49
in Health & Medicine
(AP) -- Adding the novel cancer drug Erbitux to standard chemotherapy helped advanced lung cancer patients live just a month longer than chemo alone, a study found.